• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化治疗的进展

Advances in the treatment of cystic fibrosis.

作者信息

Hopkins S

出版信息

Nurs Times. 1995;91(39):40-1.

PMID:7567556
Abstract

Cystic fibrosis is an autosomal recessive disease, characterised by pancreatic insufficiency, abnormal viscous mucus secretions and chronic respiratory tract infections. Treatment is with pancreatin preparations to improve intestinal digestion of food, but the use of high-potency products requires care. Postural drainage and other physiotherapeutic measures are essential to the relief of respiratory obstruction. A new approach to the respiratory problems of cystic fibrosis is dornase alpha, a mucolytic enzyme given by inhalation. Gene therapy may eventually provide the definitive answer to treatment and is already on the therapeutic horizon, but many practical problems remain to be solved.

摘要

囊性纤维化是一种常染色体隐性疾病,其特征为胰腺功能不全、异常黏稠的黏液分泌以及慢性呼吸道感染。治疗方法是使用胰酶制剂来改善肠道对食物的消化,但使用高效产品时需谨慎。体位引流和其他物理治疗措施对于缓解呼吸道梗阻至关重要。一种针对囊性纤维化呼吸问题的新方法是使用雾化吸入的黏液溶解酶——脱氧核糖核酸酶α。基因治疗最终可能为治疗提供决定性答案,并且已经处于治疗前景之中,但仍有许多实际问题有待解决。

相似文献

1
Advances in the treatment of cystic fibrosis.囊性纤维化治疗的进展
Nurs Times. 1995;91(39):40-1.
2
Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
Pediatr Pulmonol. 1997 Aug;24(2):124-5.
3
Dornase alfa: a new option in the management of cystic fibrosis.多纳酶α:治疗囊性纤维化的新选择。
Pharmacotherapy. 1996 Jan-Feb;16(1):40-8.
4
[Current therapeutic agents: dornase alfa].
Rev Med Brux. 1997 Feb;18(1):37-40.
5
What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
J Pediatr. 2001 Dec;139(6):768-70. doi: 10.1067/mpd.2001.120267.
6
[New pharmacological approaches: rhDNase].
Rev Pneumol Clin. 1995;51(3):193-200.
7
Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.重组人脱氧核糖核酸酶α用于囊性纤维化鼻窦疾病的术后治疗
Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1097-101. doi: 10.1001/archotol.131.12.1097.
8
[Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].[瑞士囊性纤维化患者登记处:设计、编程、实施及首个使用实例]
Schweiz Med Wochenschr. 2000 Sep 30;130(39):1373-81.
9
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.一项针对轻度肺功能异常的囊性纤维化年轻患者的为期两年的多纳酶α随机安慰剂对照试验。
J Pediatr. 2001 Dec;139(6):813-20. doi: 10.1067/mpd.2001.118570.
10
USAN Council. List No.405. New names. Dornase alfa.
Clin Pharmacol Ther. 1998 Jun;63(6):705. doi: 10.1016/S0009-9236(98)90098-4.